13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Animal Models of Chikungunya Virus Infection and Disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chikungunya virus (CHIKV) is a reemerging alphavirus that causes acute febrile illness and severe joint pain in humans. Although acute symptoms often resolve within a few days, chronic joint and muscle pain can be long lasting. In the last decade, CHIKV has caused widespread outbreaks of unprecedented scale in the Americas, Asia, and the Indian Ocean island regions. Despite these outbreaks and the continued expansion of CHIKV into new areas, mechanisms of chikungunya pathogenesis and disease are not well understood. Experimental animal models are indispensable to the field of CHIKV research. The most commonly used experimental animal models of CHIKV infection are mice and nonhuman primates; each model has its advantages for studying different aspects of CHIKV disease. This review will provide an overview of animal models used to study CHIKV infection and disease and major advances in our understanding of chikungunya obtained from studies performed in these models.

          Related collections

          Author and article information

          Journal
          J Infect Dis
          J. Infect. Dis
          jid
          jinfdis
          The Journal of Infectious Diseases
          Oxford University Press
          0022-1899
          1537-6613
          15 December 2016
          05 December 2016
          15 December 2017
          : 214
          : Suppl 5 , Gaps and Opportunities in Chikungunya Research: Expert Consultation on Chikungunya Disease in the Americas
          : S482-S487
          Affiliations
          [1 ] Vaccine and Gene Therapy Institute, Oregon Health and Science University , Beaverton
          [2 ] Department of Immunology and Microbiology, University of Colorado School of Medicine , Aurora
          [3 ] Departments of Genetics, Microbiology, and Immunology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
          Author notes

          Presented in part: Gaps and Opportunities in Chikungunya Research: Expert Consultation on Chikungunya Disease in the Americas, Rockville, Maryland, July 2015.

          [a]

          M. T. H., T. E. M., and D. N. S. contributed equally to this work.

          Correspondence: D. N. Streblow, Vaccine and Gene Therapy Institute, Oregon Health and Science University, 505 NW 185th Ave, Beaverton, OR 97006 ( streblow@ 123456ohsu.edu ).
          Article
          PMC5137241 PMC5137241 5137241 jiw284
          10.1093/infdis/jiw284
          5137241
          27920178
          9f9db957-9716-418c-92bd-12a724bca8c4
          © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
          History
          Funding
          Funded by: National Institutes of Health;
          Award ID: U19 AI109680-01
          Categories
          Chikungunya

          Alphavirus ,Chikungunya,animal models,nonhuman primates,mouse models

          Comments

          Comment on this article